Effects of a Walking Intervention in Older Patients With Chronic Kidney Disease: Feasibility Study

Chronic kidney disease (CKD) affects more than 26 million individuals (13 percent) of the U.S. population, with a projected 70 percent increase by the year 2015 to over 40 million individuals. Impairments in physical function and mobility limitations have been reported in older Chronic Kidney Disease patients, however the consequences of impaired functioning on participation in daily life and quality of life have not been studied. Early identification and interventions to mitigate deterioration in physical function and mobility should lead to improved health and quality of life outcomes in older patients with Chronic Kidney Disease. Although older individuals with Chronic Kidney Disease have reduced survival expectancy, maintaining physical function and mobility may contribute to longer active life expectancy, and higher quality of life despite their diagnosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Kidney Disease Chronic Disease Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Utah

Salt Lake City, Utah, 84112, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male and female patients over the age of 60 years
Diagnosed with moderate to severe CKD (stage 2-4)
Ambulatory (with or without use of an assistive device such as a cane or walker)
Living in the community, cognitively able to provide consent and understand directions for the tests
Cognitive ability to understand and carry out an independent home walking program
Access and ability to communicate with study staff on a weekly basis and available for follow-up testing.

Exclusion criteria

Inability to carry out a program of walking independently at home
Unavailable for follow-up testing, estimated GFR >60 ml/minx1.73m2 and < 15 ml/minx1.73 m2
Recent cardiac event (within the past 6 months)
Uncontrolled hypertension
Uncontrolled diabetes
Pulmonary disease that may limit the ability to progress with walking
Progressive neuromuscular disease
Any orthopedic or neuromuscular condition that may be exacerbated by increased walking activity
diabetic foot ulcer.

Treatment and study plan

Walking

Behavioral

Primary outcomes

walking speed

Time frame: baseline to 3 months

Sponsors and collaborators

Lead sponsor

University of Utah

Other

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registry information

Important dates

Study start: 2014
Primary completion: 2016
Study completion: 2016
First posted: Jun 4, 2014
Registry last updated: Nov 18, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed